Article(id=1329529038487532163, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329529021181833654, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.07.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1706803200000, receivedDateStr=2024-02-02, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794914024229, onlineDateStr=2026-11-17, pubDate=1720540800000, pubDateStr=2024-07-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794914024229, onlineIssueDateStr=2026-11-17, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794914024229, creator=13701087609, updateTime=1794914024229, updator=13701087609, issue=Issue{id=1329529021181833654, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='7', pageStart='697', pageEnd='798', issueExtLink='null', onlineDate='null', pubDate='1720540800000', pubDateStr='2024-07-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794914020104, creator='13701087609', updateTime=1794988140586, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329839905410233043, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329529021181833654, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329839905410233044, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329529021181833654, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=703, endPage=709, ext={EN=ArticleExt(id=1329529038663692932, articleId=1329529038487532163, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Advances in the novel treatment of metastatic triple-negative breast cancer, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Triple-negative breast cancer (TNBC) is aggressive, prone to recurrence and metastasis. There is a higher risk of early recurrence and a worse prognosis compared to other types of breast cancer. Due to the lack of specific therapeutic targets, the first-line treatment recommendations for metastatic TNBC (mTNBC) in China are still mainly based on anthracycline or paclitaxel as monotherapy or combination chemotherapy. In recent years, with the successful application of new therapeutic drugs in mTNBC, some new drugs have been approved for the treatment of mTNBC abroad. This article reviewed the recent advances in mTNBC molecular typing, immunity and antibody drug conjugations.

, authors=Jiayan FAN1, 2, Shuohan HUANG1, 2, Yanchun MENG3, Qiong DU1, 2, Jiyong LIU1, 2, Qing ZHAI1, 2, *, authorsList=Jiayan FAN, Shuohan HUANG, Yanchun MENG, Qiong DU, Jiyong LIU, Qing ZHAI, authorCompany=null, correspAuthors=Qing ZHAI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329529039011820165, articleId=1329529038487532163, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=转移性三阴性乳腺癌的新型药物治疗进展, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

三阴性乳腺癌(triple-negative breast cancer,TNBC)侵袭性强,易复发和转移。与其他类型的乳腺癌相比,TNBC早期复发风险更高,预后更差。由于缺乏特异的治疗靶点,目前国内对转移性TNBC(metastatic TNBC,mTNBC)的一线治疗推荐仍以蒽环或紫衫醇(paclitaxel)为基础的单药或联合化疗为主。近年来,随着新型治疗药物在mTNBC中的成功应用,国外已批准一些新型药物用于mTNBC的治疗。该文拟对近年来mTNBC分子分型、免疫以及抗体药物偶联物的研究进展作一综述。

, authors=范嘉躜1, 2, 黄硕涵1, 2, 孟艳春3, 杜琼1, 2, 刘继勇1, 2, 翟青1, 2, *, authorsList=范嘉躜, 黄硕涵, 孟艳春, 杜琼, 刘继勇, 翟青, authorCompany=null, correspAuthors=翟青, authorNote=

范嘉躜,药师。研究方向:临床药学。

黄硕涵,药师。研究方向:临床药学。

, correspAuthorsNote=
翟青,主任药师。研究方向:肿瘤药学。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=IrcFZJi+zhmHGvDeYVMwLw==, magXml=/v827FNHGDakywCr5EQX2A==, pdfUrl=null, pdf=2TBrwZKfFgCzjiBp2BSUTg==, pdfFileSize=1576136, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=i6ukMHAo1NElp48Pqqo24A==, mapNumber=null, fund=null)}, authors=[Author(id=1329529039573856913, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529039666131604, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529039573856913, language=EN, stringName=Jiayan FAN, firstName=Jiayan, middleName=null, lastName=FAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529039729046165, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529039573856913, language=CN, stringName=范嘉躜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.复旦大学附属肿瘤医院药剂科,上海 200032
2.复旦大学上海医学院肿瘤系,上海 200032, bio={"content":"

范嘉躜,药师。研究方向:临床药学。

"}, bioImg=null, bioContent=

范嘉躜,药师。研究方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529039288644230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=1., ext=[AuthorCompanyExt(id=1329529039309615751, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529039347364489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院药剂科,上海 200032)]), AuthorCompany(id=1329529039414473354, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=2., ext=[AuthorCompanyExt(id=1329529039422861963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329529039427056268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学上海医学院肿瘤系,上海 200032)])]), Author(id=1329529039800349335, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529039867458202, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529039800349335, language=EN, stringName=Shuohan HUANG, firstName=Shuohan, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529039934567067, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529039800349335, language=CN, stringName=黄硕涵, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.复旦大学附属肿瘤医院药剂科,上海 200032
2.复旦大学上海医学院肿瘤系,上海 200032, bio={"content":"

黄硕涵,药师。研究方向:临床药学。

"}, bioImg=null, bioContent=

黄硕涵,药师。研究方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529039288644230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=1., ext=[AuthorCompanyExt(id=1329529039309615751, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529039347364489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院药剂科,上海 200032)]), AuthorCompany(id=1329529039414473354, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=2., ext=[AuthorCompanyExt(id=1329529039422861963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329529039427056268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学上海医学院肿瘤系,上海 200032)])]), Author(id=1329529040005870237, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529040085562015, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529040005870237, language=EN, stringName=Yanchun MENG, firstName=Yanchun, middleName=null, lastName=MENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529040152670880, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529040005870237, language=CN, stringName=孟艳春, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.复旦大学附属肿瘤医院肿瘤内科,上海 200032, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529039481582221, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=3., ext=[AuthorCompanyExt(id=1329529039489970830, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039481582221, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529039498359439, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039481582221, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.复旦大学附属肿瘤医院肿瘤内科,上海 200032)])]), Author(id=1329529040223974050, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529040295277221, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529040223974050, language=EN, stringName=Qiong DU, firstName=Qiong, middleName=null, lastName=DU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529040362386086, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529040223974050, language=CN, stringName=杜琼, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.复旦大学附属肿瘤医院药剂科,上海 200032
2.复旦大学上海医学院肿瘤系,上海 200032, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529039288644230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=1., ext=[AuthorCompanyExt(id=1329529039309615751, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529039347364489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院药剂科,上海 200032)]), AuthorCompany(id=1329529039414473354, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=2., ext=[AuthorCompanyExt(id=1329529039422861963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329529039427056268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学上海医学院肿瘤系,上海 200032)])]), Author(id=1329529040421106344, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529040496603819, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529040421106344, language=EN, stringName=Jiyong LIU, firstName=Jiyong, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529040563712684, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529040421106344, language=CN, stringName=刘继勇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.复旦大学附属肿瘤医院药剂科,上海 200032
2.复旦大学上海医学院肿瘤系,上海 200032, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529039288644230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=1., ext=[AuthorCompanyExt(id=1329529039309615751, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529039347364489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院药剂科,上海 200032)]), AuthorCompany(id=1329529039414473354, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=2., ext=[AuthorCompanyExt(id=1329529039422861963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329529039427056268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学上海医学院肿瘤系,上海 200032)])]), Author(id=1329529040639210158, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329529040748262065, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529040639210158, language=EN, stringName=Qing ZHAI, firstName=Qing, middleName=null, lastName=ZHAI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529040811176626, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529040639210158, language=CN, stringName=翟青, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.复旦大学附属肿瘤医院药剂科,上海 200032
2.复旦大学上海医学院肿瘤系,上海 200032, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529039288644230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=1., ext=[AuthorCompanyExt(id=1329529039309615751, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529039347364489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院药剂科,上海 200032)]), AuthorCompany(id=1329529039414473354, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=2., ext=[AuthorCompanyExt(id=1329529039422861963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329529039427056268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学上海医学院肿瘤系,上海 200032)])])], keywords=[Keyword(id=1329529040978948787, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, language=EN, orderNo=1, keyword=metastatic triple-negative breast cancer), Keyword(id=1329529041088000692, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, language=EN, orderNo=2, keyword=immunotherapy), Keyword(id=1329529041159303861, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, language=EN, orderNo=3, keyword=antibody-drug conjugate), Keyword(id=1329529041243189942, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, language=CN, orderNo=1, keyword=转移性三阴性乳腺癌), Keyword(id=1329529041310298807, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, language=CN, orderNo=2, keyword=免疫治疗), Keyword(id=1329529041369019064, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, language=CN, orderNo=3, keyword=抗体偶联药物)], refs=[Reference(id=1329529041465488058, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Zagami P, Carey LA. Triple negative breast cancer: pitfalls and progress[J]. NPJ Breast Cancer, 2022, 8(1): 95., articleTitle=null, refAbstract=null), Reference(id=1329529041528402619, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Lehmann BD, Bauer JA, Chen X, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies[J]. J Clin Invest, 2011, 121(7): 2750-2767., articleTitle=null, refAbstract=null), Reference(id=1329529041608094396, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Rida P, Ogden A, Ellis IO, et al. First international TNBC conference meeting report[J]. Breast Cancer Res Treat, 2018, 169(3): 407-412., articleTitle=null, refAbstract=null), Reference(id=1329529041700369085, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Bauer JA, Chakravarthy AB, Rosenbluth JM, et al. Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation[J]. Clin Cancer Res, 2010, 16(2): 681-690., articleTitle=null, refAbstract=null), Reference(id=1329529041771672254, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Juul N, Szallasi Z, Eklund AC, et al. Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials[J]. Lancet Oncol, 2010, 11(4): 358-365., articleTitle=null, refAbstract=null), Reference(id=1329529041851364031, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Lehmann BD, Jovanović B, Chen X, et al. Refinement of triple-negative breast cancer molecular subtypes implications for neoadjuvant chemotherapy selection[J]. PLoS One, 2016, 11(6): e0157368., articleTitle=null, refAbstract=null), Reference(id=1329529041943638720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Jiang YZ, Ma D, Suo C, et al. Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies[J]. Cancer Cell, 2019, 35(3): 428-440., articleTitle=null, refAbstract=null), Reference(id=1329529042002358977, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Asleh K, Riaz N, Nielsen TO. Heterogeneity of triple negative breast cancer: current advances in subtyping and treatment implications[J]. J Exp Clin Cancer Res, 2022, 41(1): 265., articleTitle=null, refAbstract=null), Reference(id=1329529042073662146, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhao S, Zuo WJ, Shao ZM, et al. Molecular subtypes and precision treatment of triple-negative breast cancer[J]. Ann Transl Med, 2020, 8(7): 499., articleTitle=null, refAbstract=null), Reference(id=1329529042132382403, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=程敏, 史玉洁, 孔令非. 乳腺癌中p53、PD-1和PD-L1的表达及相关性分析[J]. 临床与实验病理学杂志, 2018, 34(12): 1307-1310., articleTitle=null, refAbstract=null), Reference(id=1329529042191102660, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=韩佳澍, 谢霄鹤, 吴孟闱, 等. 三阴性乳腺癌免疫治疗进展[J]. 肿瘤, 2022, 42(9): 591-601., articleTitle=null, refAbstract=null), Reference(id=1329529042254017221, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Winer EP, Lipatov O, Im SA, et al. Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial[J]. Lancet Oncol, 2021, 22(4): 499-511., articleTitle=null, refAbstract=null), Reference(id=1329529042316931782, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Keenan TE, Tolaney SM. Role of immunotherapy in triple-negative breast cancer[J]. Natl Compr Canc Netw, 2020, 18(4): 479-489., articleTitle=null, refAbstract=null), Reference(id=1329529042379846343, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Schmid P, Adams S, Rugo HS, et al. Atezolizumab and nab-paclitaxel inadvanced triple-negative breast cancer[J]. N Engl J Med, 2018, 379(22): 2108-2121., articleTitle=null, refAbstract=null), Reference(id=1329529042455343816, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Bartsch R. SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer[J]. Memo, 2021, 14(3): 247-251., articleTitle=null, refAbstract=null), Reference(id=1329529042518258377, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Cortes J, Cescon DW, Rugo HS, et al. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial[J]. Lancet, 2020, 396(10265): 1817-1828., articleTitle=null, refAbstract=null), Reference(id=1329529042606338762, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Rugo HS, Schmid P, Cescon DW, et al. Abstract GS3-01: additional efficacy endpoints from the phase 3 KEYNOTE-355 study of pembrolizumab plus chemotherapy vs placebo plus chemotherapy as first-line therapy for locally recurrent inoperable or metastatic triple-negative breast cancer[J]. Cancer Res, 2021, 81(4 supplement): GS3-01., articleTitle=null, refAbstract=null), Reference(id=1329529042669253323, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=National Comprehensive Cancer Network. Breast cancer version 4. 2023[EB/OL]. [2023-12-09]. https://www.nccnchina.org.cn/guide/detail/646, articleTitle=null, refAbstract=null), Reference(id=1329529042732167884, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Yi M, Jiao D, Qin S, et al. Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment[J]. Mol Cancer, 2019, 18(1): 60., articleTitle=null, refAbstract=null), Reference(id=1329529042811859661, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Chen L, Jiang YZ, Wu SY, et al. Famitinib with Camrelizumab and nab-paclitaxel for advanced immunomodulatory triple-negative breast cancer (FUTURE-C-plus): an open-label, single-arm, phaseⅡ trial[J]. Clin Cancer Res, 2022, 28(13): 2807-2817., articleTitle=null, refAbstract=null), Reference(id=1329529042874774222, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Li Q, Zhang Q, Zhang Y, et al. Abstract PD11-10: PD11-10 efficacy, safety, and tolerability of KN046 (an anti-PD-L1/CTLA-4 bispecific antibody) in combination with nab-paclitaxel in metastatic triple-negative breast cancer (mTNBC): final results of the phase Ⅱ trial[J]. Cancer Res, 2023, 83(5 Suppl): PD11-10., articleTitle=null, refAbstract=null), Reference(id=1329529042933494479, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=曾弘烨, 宁文静, 罗文新. ADC药物的抗体组成及其作用靶点研究进展[J]. 中国生物工程杂志, 2022, 42(5): 69-80., articleTitle=null, refAbstract=null), Reference(id=1329529042992214736, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=杨慧欣, 钱莹莹, 黄旭, 等. 抗HER2乳腺癌ADC药物研究进展[J]. 中国老年学杂志, 2023, 43(2): 500-506., articleTitle=null, refAbstract=null), Reference(id=1329529043055129297, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=S Modi, W Jacot, T Yamashita, et al. Trastuzumab deruxtecan (T-DXd) versus treatment of physician's choice (TPC) in patients (pts) with HER2-low unresectable and/or metastatic breast cancer (mBC): results of DESTINY-Breast04, a randomized, phase 3 study[C]//America: American Society of Clinical Oncology, 2022., articleTitle=null, refAbstract=null), Reference(id=1329529043139015378, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Rugo HS, Jacot W, Tokunaga E, et al. Trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) in patients (pts) with HER2-low unresectable and/or metastatic breast cancer (mBC): a detailed safety analysis of the randomized, phase 3 DESTINY-Breast04 trial[C]//Madrid: European Society of Medical Oncology, 2023., articleTitle=null, refAbstract=null), Reference(id=1329529043235484371, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=黄琎燚, 王岑竹, 汪润添, 等. 三阴性乳腺癌含抗体偶联药物治疗方案的临床研究解析[J]. 中国临床研究, 2023, 36(7): 1012-1017., articleTitle=null, refAbstract=null), Reference(id=1329529043315176148, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Bardia A, Hurvitz SA, Tolaney SM, et al. Sacituzumab govitecan in metastatic triple-negative breast cancer[J]. N Engl J Med, 2021, 384(16): 1529-1541., articleTitle=null, refAbstract=null), Reference(id=1329529043390673621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Xu B, Ma F, Wang T, et al. A phase Ⅱb, single arm, multicenter trial of sacituzumab govitecan in Chinese patients with metastatic triple-negative breast cancer who received at least two prior treatments[J]. Int J Cancer, 2023, 152(10): 2134-2144., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329529039288644230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=1., ext=[AuthorCompanyExt(id=1329529039309615751, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529039347364489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院药剂科,上海 200032)]), AuthorCompany(id=1329529039414473354, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=2., ext=[AuthorCompanyExt(id=1329529039422861963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329529039427056268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学上海医学院肿瘤系,上海 200032)]), AuthorCompany(id=1329529039481582221, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=3., ext=[AuthorCompanyExt(id=1329529039489970830, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039481582221, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529039498359439, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039481582221, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.复旦大学附属肿瘤医院肿瘤内科,上海 200032)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.07.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.07.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.07.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.07.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1720540800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
转移性三阴性乳腺癌的新型药物治疗进展
范嘉躜 1, 2 , 黄硕涵 1, 2 , 孟艳春 3 , 杜琼 1, 2 , 刘继勇 1, 2 , 翟青 1, 2, *
世界临床药物 | 医药专论 2024,45(7): 703-709
收起
收藏切换
世界临床药物 |医药专论 2024 , 45 (7) : 703 -709
转移性三阴性乳腺癌的新型药物治疗进展
全屏
[Author(id=1329529039573856913, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529039666131604, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529039573856913, language=EN, stringName=Jiayan FAN, firstName=Jiayan, middleName=null, lastName=FAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529039729046165, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529039573856913, language=CN, stringName=范嘉躜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.复旦大学附属肿瘤医院药剂科,上海 200032
2.复旦大学上海医学院肿瘤系,上海 200032, bio={"content":"

范嘉躜,药师。研究方向:临床药学。

"}, bioImg=null, bioContent=

范嘉躜,药师。研究方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529039288644230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=1., ext=[AuthorCompanyExt(id=1329529039309615751, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529039347364489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院药剂科,上海 200032)]), AuthorCompany(id=1329529039414473354, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=2., ext=[AuthorCompanyExt(id=1329529039422861963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329529039427056268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学上海医学院肿瘤系,上海 200032)])]), Author(id=1329529039800349335, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529039867458202, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529039800349335, language=EN, stringName=Shuohan HUANG, firstName=Shuohan, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529039934567067, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529039800349335, language=CN, stringName=黄硕涵, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.复旦大学附属肿瘤医院药剂科,上海 200032
2.复旦大学上海医学院肿瘤系,上海 200032, bio={"content":"

黄硕涵,药师。研究方向:临床药学。

"}, bioImg=null, bioContent=

黄硕涵,药师。研究方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529039288644230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=1., ext=[AuthorCompanyExt(id=1329529039309615751, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529039347364489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院药剂科,上海 200032)]), AuthorCompany(id=1329529039414473354, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=2., ext=[AuthorCompanyExt(id=1329529039422861963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329529039427056268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学上海医学院肿瘤系,上海 200032)])]), Author(id=1329529040005870237, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529040085562015, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529040005870237, language=EN, stringName=Yanchun MENG, firstName=Yanchun, middleName=null, lastName=MENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529040152670880, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529040005870237, language=CN, stringName=孟艳春, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.复旦大学附属肿瘤医院肿瘤内科,上海 200032, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529039481582221, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=3., ext=[AuthorCompanyExt(id=1329529039489970830, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039481582221, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529039498359439, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039481582221, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.复旦大学附属肿瘤医院肿瘤内科,上海 200032)])]), Author(id=1329529040223974050, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529040295277221, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529040223974050, language=EN, stringName=Qiong DU, firstName=Qiong, middleName=null, lastName=DU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529040362386086, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529040223974050, language=CN, stringName=杜琼, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.复旦大学附属肿瘤医院药剂科,上海 200032
2.复旦大学上海医学院肿瘤系,上海 200032, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529039288644230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=1., ext=[AuthorCompanyExt(id=1329529039309615751, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529039347364489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院药剂科,上海 200032)]), AuthorCompany(id=1329529039414473354, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=2., ext=[AuthorCompanyExt(id=1329529039422861963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329529039427056268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学上海医学院肿瘤系,上海 200032)])]), Author(id=1329529040421106344, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529040496603819, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529040421106344, language=EN, stringName=Jiyong LIU, firstName=Jiyong, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529040563712684, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529040421106344, language=CN, stringName=刘继勇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.复旦大学附属肿瘤医院药剂科,上海 200032
2.复旦大学上海医学院肿瘤系,上海 200032, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529039288644230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=1., ext=[AuthorCompanyExt(id=1329529039309615751, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529039347364489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院药剂科,上海 200032)]), AuthorCompany(id=1329529039414473354, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=2., ext=[AuthorCompanyExt(id=1329529039422861963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329529039427056268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学上海医学院肿瘤系,上海 200032)])]), Author(id=1329529040639210158, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329529040748262065, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529040639210158, language=EN, stringName=Qing ZHAI, firstName=Qing, middleName=null, lastName=ZHAI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529040811176626, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, authorId=1329529040639210158, language=CN, stringName=翟青, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.复旦大学附属肿瘤医院药剂科,上海 200032
2.复旦大学上海医学院肿瘤系,上海 200032, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529039288644230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=1., ext=[AuthorCompanyExt(id=1329529039309615751, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529039347364489, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039288644230, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院药剂科,上海 200032)]), AuthorCompany(id=1329529039414473354, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, xref=2., ext=[AuthorCompanyExt(id=1329529039422861963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329529039427056268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529038487532163, companyId=1329529039414473354, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学上海医学院肿瘤系,上海 200032)])])]
范嘉躜1, 2, 黄硕涵1, 2, 孟艳春3, 杜琼1, 2, 刘继勇1, 2, 翟青1, 2, *
作者信息
  • 1.复旦大学附属肿瘤医院药剂科,上海 200032
  • 2.复旦大学上海医学院肿瘤系,上海 200032
  • 3.复旦大学附属肿瘤医院肿瘤内科,上海 200032
通讯作者:
翟青,主任药师。研究方向:肿瘤药学。
作者简介:

范嘉躜,药师。研究方向:临床药学。

黄硕涵,药师。研究方向:临床药学。

Advances in the novel treatment of metastatic triple-negative breast cancer
Jiayan FAN1, 2, Shuohan HUANG1, 2, Yanchun MENG3, Qiong DU1, 2, Jiyong LIU1, 2, Qing ZHAI1, 2, *
Affiliations
  • 1.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
  • 2.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • 3.Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China
出版时间: 2024-07-10 doi: 10.13683/j.wph.2024.07.002
文章导航
收藏切换

三阴性乳腺癌(triple-negative breast cancer,TNBC)侵袭性强,易复发和转移。与其他类型的乳腺癌相比,TNBC早期复发风险更高,预后更差。由于缺乏特异的治疗靶点,目前国内对转移性TNBC(metastatic TNBC,mTNBC)的一线治疗推荐仍以蒽环或紫衫醇(paclitaxel)为基础的单药或联合化疗为主。近年来,随着新型治疗药物在mTNBC中的成功应用,国外已批准一些新型药物用于mTNBC的治疗。该文拟对近年来mTNBC分子分型、免疫以及抗体药物偶联物的研究进展作一综述。

转移性三阴性乳腺癌  /  免疫治疗  /  抗体偶联药物

Triple-negative breast cancer (TNBC) is aggressive, prone to recurrence and metastasis. There is a higher risk of early recurrence and a worse prognosis compared to other types of breast cancer. Due to the lack of specific therapeutic targets, the first-line treatment recommendations for metastatic TNBC (mTNBC) in China are still mainly based on anthracycline or paclitaxel as monotherapy or combination chemotherapy. In recent years, with the successful application of new therapeutic drugs in mTNBC, some new drugs have been approved for the treatment of mTNBC abroad. This article reviewed the recent advances in mTNBC molecular typing, immunity and antibody drug conjugations.

metastatic triple-negative breast cancer  /  immunotherapy  /  antibody-drug conjugate
范嘉躜, 黄硕涵, 孟艳春, 杜琼, 刘继勇, 翟青. 转移性三阴性乳腺癌的新型药物治疗进展. 世界临床药物, 2024 , 45 (7) : 703 -709 . DOI: 10.13683/j.wph.2024.07.002
Jiayan FAN, Shuohan HUANG, Yanchun MENG, Qiong DU, Jiyong LIU, Qing ZHAI. Advances in the novel treatment of metastatic triple-negative breast cancer[J]. World Clinical Drug, 2024 , 45 (7) : 703 -709 . DOI: 10.13683/j.wph.2024.07.002

参考文献 引证文献
排序方式:
[1]
Zagami P, Carey LA. Triple negative breast cancer: pitfalls and progress[J]. NPJ Breast Cancer, 2022, 8(1): 95.
[2]
Lehmann BD, Bauer JA, Chen X, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies[J]. J Clin Invest, 2011, 121(7): 2750-2767.
[3]
Rida P, Ogden A, Ellis IO, et al. First international TNBC conference meeting report[J]. Breast Cancer Res Treat, 2018, 169(3): 407-412.
[4]
Bauer JA, Chakravarthy AB, Rosenbluth JM, et al. Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation[J]. Clin Cancer Res, 2010, 16(2): 681-690.
[5]
Juul N, Szallasi Z, Eklund AC, et al. Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials[J]. Lancet Oncol, 2010, 11(4): 358-365.
[6]
Lehmann BD, Jovanović B, Chen X, et al. Refinement of triple-negative breast cancer molecular subtypes implications for neoadjuvant chemotherapy selection[J]. PLoS One, 2016, 11(6): e0157368.
[7]
Jiang YZ, Ma D, Suo C, et al. Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies[J]. Cancer Cell, 2019, 35(3): 428-440.
[8]
Asleh K, Riaz N, Nielsen TO. Heterogeneity of triple negative breast cancer: current advances in subtyping and treatment implications[J]. J Exp Clin Cancer Res, 2022, 41(1): 265.
[9]
Zhao S, Zuo WJ, Shao ZM, et al. Molecular subtypes and precision treatment of triple-negative breast cancer[J]. Ann Transl Med, 2020, 8(7): 499.
[10]
程敏, 史玉洁, 孔令非. 乳腺癌中p53、PD-1和PD-L1的表达及相关性分析[J]. 临床与实验病理学杂志, 2018, 34(12): 1307-1310.
[11]
韩佳澍, 谢霄鹤, 吴孟闱, 等. 三阴性乳腺癌免疫治疗进展[J]. 肿瘤, 2022, 42(9): 591-601.
[12]
Winer EP, Lipatov O, Im SA, et al. Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial[J]. Lancet Oncol, 2021, 22(4): 499-511.
[13]
Keenan TE, Tolaney SM. Role of immunotherapy in triple-negative breast cancer[J]. Natl Compr Canc Netw, 2020, 18(4): 479-489.
[14]
Schmid P, Adams S, Rugo HS, et al. Atezolizumab and nab-paclitaxel inadvanced triple-negative breast cancer[J]. N Engl J Med, 2018, 379(22): 2108-2121.
[15]
Bartsch R. SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer[J]. Memo, 2021, 14(3): 247-251.
[16]
Cortes J, Cescon DW, Rugo HS, et al. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial[J]. Lancet, 2020, 396(10265): 1817-1828.
[17]
Rugo HS, Schmid P, Cescon DW, et al. Abstract GS3-01: additional efficacy endpoints from the phase 3 KEYNOTE-355 study of pembrolizumab plus chemotherapy vs placebo plus chemotherapy as first-line therapy for locally recurrent inoperable or metastatic triple-negative breast cancer[J]. Cancer Res, 2021, 81(4 supplement): GS3-01.
[18]
National Comprehensive Cancer Network. Breast cancer version 4. 2023[EB/OL]. [2023-12-09]. https://www.nccnchina.org.cn/guide/detail/646
[19]
Yi M, Jiao D, Qin S, et al. Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment[J]. Mol Cancer, 2019, 18(1): 60.
[20]
Chen L, Jiang YZ, Wu SY, et al. Famitinib with Camrelizumab and nab-paclitaxel for advanced immunomodulatory triple-negative breast cancer (FUTURE-C-plus): an open-label, single-arm, phaseⅡ trial[J]. Clin Cancer Res, 2022, 28(13): 2807-2817.
[21]
Li Q, Zhang Q, Zhang Y, et al. Abstract PD11-10: PD11-10 efficacy, safety, and tolerability of KN046 (an anti-PD-L1/CTLA-4 bispecific antibody) in combination with nab-paclitaxel in metastatic triple-negative breast cancer (mTNBC): final results of the phase Ⅱ trial[J]. Cancer Res, 2023, 83(5 Suppl): PD11-10.
[22]
曾弘烨, 宁文静, 罗文新. ADC药物的抗体组成及其作用靶点研究进展[J]. 中国生物工程杂志, 2022, 42(5): 69-80.
[23]
杨慧欣, 钱莹莹, 黄旭, 等. 抗HER2乳腺癌ADC药物研究进展[J]. 中国老年学杂志, 2023, 43(2): 500-506.
[24]
S Modi, W Jacot, T Yamashita, et al. Trastuzumab deruxtecan (T-DXd) versus treatment of physician's choice (TPC) in patients (pts) with HER2-low unresectable and/or metastatic breast cancer (mBC): results of DESTINY-Breast04, a randomized, phase 3 study[C]//America: American Society of Clinical Oncology, 2022.
[25]
Rugo HS, Jacot W, Tokunaga E, et al. Trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) in patients (pts) with HER2-low unresectable and/or metastatic breast cancer (mBC): a detailed safety analysis of the randomized, phase 3 DESTINY-Breast04 trial[C]//Madrid: European Society of Medical Oncology, 2023.
[26]
黄琎燚, 王岑竹, 汪润添, 等. 三阴性乳腺癌含抗体偶联药物治疗方案的临床研究解析[J]. 中国临床研究, 2023, 36(7): 1012-1017.
[27]
Bardia A, Hurvitz SA, Tolaney SM, et al. Sacituzumab govitecan in metastatic triple-negative breast cancer[J]. N Engl J Med, 2021, 384(16): 1529-1541.
[28]
Xu B, Ma F, Wang T, et al. A phase Ⅱb, single arm, multicenter trial of sacituzumab govitecan in Chinese patients with metastatic triple-negative breast cancer who received at least two prior treatments[J]. Int J Cancer, 2023, 152(10): 2134-2144.
2024年第45卷第7期
18
4
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2024.07.002
  • 接收时间:2024-02-02
  • 首发时间:2026-11-17
  • 出版时间:2024-07-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-02-02
基金
作者信息
    1.复旦大学附属肿瘤医院药剂科,上海 200032
    2.复旦大学上海医学院肿瘤系,上海 200032
    3.复旦大学附属肿瘤医院肿瘤内科,上海 200032

通讯作者:

翟青,主任药师。研究方向:肿瘤药学。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.07.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏